ESMO FAMILY SITES
Information for press representatives
ESMO 2012: a congress of firsts, another of excellence
A path for medical oncology innovations
“Our goal is to trigger the conversations that will help us all prepare for – and respond to – the rapidly changing times which are in many respects as daunting as they are promising. As our knowledge of cancer biology improves and new approaches to treatment and diagnosis develop, the management of cancer patients will continue to change substantially. The identification of new biomarkers is increasingly supporting the development of targeted drugs, which pose crucial challenges for the daily practice: Who will really benefit from them? Can we manage all possible side-effects? Are these new drugs affordable? How can we best respond and adapt to new and emerging treatment approaches and paradigms?
These are just some of the many questions that will be addressed during the discussions at ESMO 2012, with state-of-the-art education and best practices, presentations and conversations with top experts from various disciplines, controversial debates and, of course, the very latest cutting-edge research.The ESMO Congress is the definitive platform upon which to join us in collectively shaping the future of medical oncology.” Josep Tabernero, ESMO 2012 Scientific Chair
A total of 134 sessions, of which 119 presenting top scientific results on cancer research progress in 2012, 15 ‘purely’ educational sessions to bring everybody up to speed on state-of-the-art oncology; approximately 200 presentations with 278 international experts sharing best knowledge in cancer research, treatment and patient care, for a total of 170 program hours: the oncology community can only expect the best from ESMO 2012!
17,000 participants from 125 different countries are estimated, including oncology professionals, healthcare policy makers, patient groups, pharmaceutical industry, cancer foundations, media, general public and 85 exhibitors.
Media registration
ESMO welcomes media interested in obtaining information and reporting on cancer issues. Registration is free to bona fide journalists on presentation of a letter of assignment and a valid press card.
Media representatives are required to observe and abide by the ESMO Media Policy (pdf) which applies to all ESMO events.
To register for the event, please fill out the Complimentary Media Registration Form. Or you can directly complete the form from your smartphone:
Media registration in advance is strongly recommended although on-site registration will still be possible. Further information for press representatives will be made available over the following months. Please contact the ESMO Press Office for any additional question.
Third-party’s media activities
Media activities initiated by third parties during or in connection with the ESMO Congress, including (but not limited to):
• Meetings such as press conferences, media briefings, educational sessions for media representatives
• PR activities, such as press releases, news, articles, interviews, etc.
are subject to the ESMO Policy on Third-Party’s Media Activity (pdf).
This policy aims to guarantee proper and correct distribution of oncology and cancer-related information to media representatives in connection with the ESMO Congress.
Press events in or outside the congress center but concomitant with or during breaks of the scientific program of the ESMO Congress are subject to ESMO Press Office.
Please use the online form to submit the first request for media activities.
ESMO Press Office
E-mail: media@esmo.org
BACK TO TOP
PRINT THIS PAGE